--- title: "Sunshine Lake Pharma Co. (6887) stock and investor profile" url: "https://aibio.space/companies/sunshine-lake-pharma/" publisher: "aibio.space (Biotech Investor Relations News)" summary: "Sunshine Lake Pharma Co., Ltd. (HKEX: 6887), China. The directory classifies it as Biotechnology." --- 6887 Sunshine Lake Pharma Co., Ltd. HKEX · China # Sunshine Lake Pharma Co. (6887) news Sunshine Lake Pharma Co., Ltd. is a public biotech or pharmaceutical company listed on HKEX under the ticker 6887, recorded under China. The directory classifies it as Biotechnology. aibio.space tracks 2,820 public biotech companies worldwide and publishes investor news on them. ## Latest Sunshine Lake Pharma Co. news We have not published a story on Sunshine Lake Pharma Co. yet. When there is news, it will appear here. ## Sunshine Lake Pharma Co. at a glance - **Ticker**: 6887 - **Listing**: HKEX - **Country**: China ### Related companies - [TransThera Sciences (Nanjing).](https://aibio.space/companies/transthera-sciences-nanjing/) HKEX: 2617 - [Jiangsu Cowin Biotech Co.](https://aibio.space/companies/jiangsu-cowin-biotech/) SSE: 688426 - [Ascletis Pharma](https://aibio.space/companies/ascletis-pharma/) HKEX: 1672 - [Edding Genor Group Holdings](https://aibio.space/companies/edding-genor/) HKEX: 6998 - [PegBio Co.](https://aibio.space/companies/pegbio/) HKEX: 2565 - [Laekna](https://aibio.space/companies/laekna/) HKEX: 2105 - [Beijing Kawin Technology Share-Holding Co.](https://aibio.space/companies/beijing-kawin-technology-share/) SSE: 688687 - [EVOPOINT BIOSCIENCES CO LTD](https://aibio.space/companies/evopoint-biosciences/) SSE: 688837 ### Also on HKEX - [Clover Biopharmaceuticals](https://aibio.space/companies/clover-biopharmaceuticals/) 2197 - [China Biotech Services Holdings](https://aibio.space/companies/china-biotech-services/) 8037 - [Tianda Pharmaceuticals](https://aibio.space/companies/tianda-pharmaceuticals/) 455 - [Dawnrays Pharmaceutical Holdings](https://aibio.space/companies/dawnrays-pharmaceutical/) 2348 - [Beijing Luzhu Biotechnology Co.](https://aibio.space/companies/beijing-luzhu-biotechnology/) 2480 - [Hanx Biopharmaceuticals (Wuhan) Co.](https://aibio.space/companies/hanx-biopharmaceuticals-wuhan/) 3378 ## Questions about Sunshine Lake Pharma Co. What is the ticker symbol of Sunshine Lake Pharma Co.? Sunshine Lake Pharma Co., Ltd. trades under the ticker 6887 on HKEX. Where is Sunshine Lake Pharma Co. listed? Sunshine Lake Pharma Co., Ltd. is listed on HKEX. Which country or territory is Sunshine Lake Pharma Co. listed under? Our directory records Sunshine Lake Pharma Co., Ltd. under China. What does Sunshine Lake Pharma Co. do? Our directory classifies Sunshine Lake Pharma Co., Ltd. as: Biotechnology. This is a directory classification, not a description of the pipeline. What is the ISIN of Sunshine Lake Pharma Co.? The ISIN recorded for Sunshine Lake Pharma Co., Ltd. is CNE1000070M8. Does aibio.space cover Sunshine Lake Pharma Co.? aibio.space lists Sunshine Lake Pharma Co., Ltd. among 2,820 public biotech companies and publishes its news here as stories appear. Which companies are similar to Sunshine Lake Pharma Co.? Companies in our directory listed in the same country and business area as Sunshine Lake Pharma Co.: TransThera Sciences (Nanjing)., Jiangsu Cowin Biotech Co., Ascletis Pharma, Edding Genor Group Holdings, PegBio Co., Laekna. ## Investor discussion: Sunshine Lake Pharma Co. Members talk about Sunshine Lake Pharma Co. (6887). Reader posts, not aibio.space reporting, and not investment advice. Rules 1. **Securities violations are strictly forbidden.** No market manipulation, no pump-and-dump, no false or misleading statements, and no inside information. 2. **Say whether you hold the stock.** Every post states long, short or no position. 3. **No paid or sponsored posts.** Do not post for anyone who pays or rewards you. 4. **No buy or sell calls and no price targets.** 5. **No accusations of crime or fraud against named people** unless you link a court filing or a regulator's release that makes them. 6. **No personal details and no spam.** No links at all for your first 7 days as a member. Posts that break the rules may be deleted without notice, and the account restricted or closed. See the [terms](https://aibio.space/terms/#discussion) and the [privacy policy](https://aibio.space/privacy/#discussion). ## Capital-markets timeline Financings, listing notices, splits, legal actions and other investor events at Sunshine Lake Pharma Co., newest first. Each line links the filing it comes from. 1. 2025-11-28 Financings Share or debt issue: (1) PROPOSED GRANT OF REPURCHASE MANDATE; (2) PROPOSED EXTENSION OF GENERAL ISSUE MANDATE; (3) PROPOSED AMENDMENTS TO THE ARTICLES OF ASSOCIATION; AND (4) NOTICE OF THE 2025 SECOND EXTRAORDINARY GENERAL MEETING. [Source](https://www1.hkexnews.hk/listedco/listconews/sehk/2025/1128/2025112800571.pdf) 2. 2025-08-19 Financings Share or debt issue: PROPOSED GRANT OF GENERAL ISSUE MANDATE AND NOTICE OF THE 2025 FIRST EXTRAORDINARY GENERAL MEETING. [Source](https://www1.hkexnews.hk/listedco/listconews/sehk/2025/0819/2025081901516.pdf) 3. 2025-08-06 Listings Trading status: JOINT ANNOUNCEMENT UPDATE REGARDING CONDITIONAL PRIVATISATION OF YICHANG HEC CHANGJIANG PHARMACEUTICAL CO., LTD. BY SUNSHINE LAKE PHARMA CO., LTD. BY WAY OF MERGER BY ABSORPTION OF YICHANG HEC CHANGJIANG PHARMACEUTICAL CO., LTD. (1) SATISFACTION OF CONDITIONS TO IMPLEMENTATION AND IMPLEMENTATION OF THE MERGER (2) APPOINTMENT OF AGENT FOR ODD LOT ARRANGEMENT. [Source](https://www1.hkexnews.hk/listedco/listconews/sehk/2025/0807/2025080700001.pdf) 4. 2025-08-04 Listings Trading status: JOINT ANNOUNCEMENT WITHDRAWAL OF LISTING OF H SHARES AND EXPECTED TIMELINE FOR THE WITHDRAWAL OF LISTING AND THE IMPLEMENTATION OF THE SHARE EXCHANGE. [Source](https://www1.hkexnews.hk/listedco/listconews/sehk/2025/0805/2025080500027.pdf) 5. 2025-07-31 Mergers Transaction under the Listing Rules: JOINT ANNOUNCEMENT IN RESPECT OF THE SPECIAL DIVIDEND. [Source](https://www1.hkexnews.hk/listedco/listconews/sehk/2025/0731/2025073101476.pdf) 6. 2025-07-23 Listings Trading status: JOINT ANNOUNCEMENT RESULTS OF EXERCISE OF RIGHT OF DISSENTING SHAREHOLDERS. [Source](https://www1.hkexnews.hk/listedco/listconews/sehk/2025/0723/2025072300950.pdf) 7. 2025-07-21 Listings Trading status: JOINT ANNOUNCEMENT (1) POLL RESULTS OF THE EGM AND THE H SHAREHOLDERS' CLASS MEETING HELD ON MONDAY, 21 JULY 2025 RELATING TO THE PROPOSED CONDITIONAL PRIVATISATION OF YICHANG HEC CHANGJIANG PHARMACEUTICAL CO., LTD. BY SUNSHINE LAKE PHARMA CO., LTD. BY WAY OF MERGER BY ABSORPTION OF YICHANG HEC CHANGJIANG PHARMACEUTICAL CO., LTD. (2) PROPOSED WITHDRAWAL OF LISTING AND LAST DAY OF TRADING (3) PROPOSED SPECIAL DIVIDEND AND (4) INFORMATION REGARDING EXERCISE OF RIGHT OF DISSENTING SHAREHOLDERS. [Source](https://www1.hkexnews.hk/listedco/listconews/sehk/2025/0721/2025072101084.pdf) 8. 2025-06-29 Listings Trading status: COMPOSITE DOCUMENT (1) PROPOSED CONDITIONAL PRIVATISATION OF YICHANG HEC CHANGJIANG PHARMACEUTICAL CO., LTD. BY SUNSHINE LAKE PHARMA CO., LTD. BY WAY OF MERGER BY ABSORPTION OF YICHANG HEC CHANGJIANG PHARMACEUTICAL CO., LTD. (2) PROPOSED SPECIAL DIVIDEND (3) PROPOSED WITHDRAWAL OF LISTING (4) NOTICE OF EXTRAORDINARY GENERAL MEETING AND (5) NOTICE OF THE H SHAREHOLDERS' CLASS MEETING. [Source](https://www1.hkexnews.hk/listedco/listconews/sehk/2025/0629/2025062900231.pdf) 9. 2025-06-29 Listings Trading status: JOINT ANNOUNCEMENT (1) PROPOSED CONDITIONAL PRIVATISATION OF YICHANG HEC CHANGJIANG PHARMACEUTICAL CO., LTD. BY SUNSHINE LAKE PHARMA CO., LTD. BY WAY OF MERGER BY ABSORPTION OF YICHANG HEC CHANGJIANG PHARMACEUTICAL CO., LTD. (2) PROPOSED WITHDRAWAL OF LISTING AND (3) DESPATCH OF COMPOSITE DOCUMENT. [Source](https://www1.hkexnews.hk/listedco/listconews/sehk/2025/0629/2025062900221.pdf) ## Press releases Headlines of Sunshine Lake Pharma Co.'s own announcements, newest first. Each opens the full release on the newswire that carried it. 1. 2026-10-08 HKEXnews [VOLUNTARY ANNOUNCEMENT INSULIN DEGLUDEC AND INSULIN ASPART INJECTION OBTAINED MARKETING APPROVAL FROM THE CHINA NATIONAL MEDICAL PRODUCTS ADMINISTRATION](https://www1.hkexnews.hk/listedco/listconews/sehk/2026/1008/2026100800947.pdf) 2. 2026-09-23 HKEXnews [INSIDE INFORMATION FILING WITH THE CSRC IN RELATION TO THE PROPOSED IMPLEMENTATION OF H SHARE FULL CIRCULATION](https://www1.hkexnews.hk/listedco/listconews/sehk/2026/0923/2026092301281.pdf) 3. 2026-08-31 HKEXnews [SUPPLEMENTAL ANNOUNCEMENT WITH RESPECT TO CONNECTED TRANSACTIONS](https://www1.hkexnews.hk/listedco/listconews/sehk/2026/0831/2026083102857.pdf) 4. 2026-08-31 HKEXnews [CHANGE OF COMPLIANCE ADVISER](https://www1.hkexnews.hk/listedco/listconews/sehk/2026/0831/2026083100866.pdf) 5. 2026-08-31 HKEXnews [INTERIM RESULTS ANNOUNCEMENT FOR THE SIX MONTHS ENDED 30 JUNE 2026](https://www1.hkexnews.hk/listedco/listconews/sehk/2026/0831/2026083100826.pdf) 6. 2026-08-24 HKEXnews [PROFIT WARNING](https://www1.hkexnews.hk/listedco/listconews/sehk/2026/0824/2026082402015.pdf) 7. 2026-07-31 HKEXnews [VOLUNTARY ANNOUNCEMENT FIRST COMMERCIAL SHIPMENT OF INSULIN GLARGINE INJECTION TO THE UNITED STATES](https://www1.hkexnews.hk/listedco/listconews/sehk/2026/0731/2026073101161.pdf) 8. 2026-07-30 HKEXnews [VOLUNTARY ANNOUNCEMENT IN RELATION TO THE MARKETING APPROVAL OF INSULIN DEGLUDEC INJECTION BY THE NATIONAL MEDICAL PRODUCTS ADMINISTRATION (NMPA)](https://www1.hkexnews.hk/listedco/listconews/sehk/2026/0730/2026073001697.pdf) 9. 2026-07-30 HKEXnews [VOLUNTARY ANNOUNCEMENT UPDATE ON PROPOSED INCREASE IN SHAREHOLDING IN THE COMPANY BY THE CONTROLLING SHAREHOLDER AND DIRECTOR](https://www1.hkexnews.hk/listedco/listconews/sehk/2026/0730/2026073001657.pdf) 10. 2026-07-20 HKEXnews [VOLUNTARY ANNOUNCEMENT (1) PROPOSED INCREASE IN SHAREHOLDING IN THE COMPANY BY THE CONTROLLING SHAREHOLDER AND DIRECTOR; AND (2) ON-MARKET SHARE REPURCHASE](https://www1.hkexnews.hk/listedco/listconews/sehk/2026/0720/2026072001467.pdf) 11. 2026-07-17 HKEXnews [VOLUNTARY ANNOUNCEMENT (1) UNUSUAL PRICE AND TRADING VOLUME MOVEMENTS; AND (2) BUSINESS UPDATE](https://www1.hkexnews.hk/listedco/listconews/sehk/2026/0717/2026071701177.pdf) 12. 2026-06-26 HKEXnews [CONNECTED TRANSACTION (1) ESTABLISHMENT OF LIMITED PARTNERSHIP FUND; AND (2) ACQUISITION OF LAND USE RIGHTS](https://www1.hkexnews.hk/listedco/listconews/sehk/2026/0626/2026062603041.pdf) 13. 2026-06-18 HKEXnews [ELECTION OF CHAIRMAN OF THE BOARD; APPOINTMENT OF MEMBERS OF EACH OF THE BOARD COMMITTEES; AND ENGAGEMENT OF SENIOR MANAGEMENT OF THE COMPANY](https://www1.hkexnews.hk/listedco/listconews/sehk/2026/0618/2026061802166.pdf) 14. 2026-06-18 HKEXnews [ARTICLES OF ASSOCIATION](https://www1.hkexnews.hk/listedco/listconews/sehk/2026/0618/2026061802160.pdf) 15. 2026-06-18 HKEXnews [POLL RESULTS OF THE 2025 ANNUAL GENERAL MEETING AND ELECTION OF EMPLOYEE DIRECTOR TO THE SECOND SESSION OF THE BOARD](https://www1.hkexnews.hk/listedco/listconews/sehk/2026/0618/2026061802120.pdf) 16. 2026-06-18 HKEXnews [VOLUNTARY ANNOUNCEMENT CLINICAL TRIAL APPLICATION FOR NOVEL LY6G6D/4-1BB-TARGETING BISPECIFIC ANTIBODY HEC-921 INJECTION ACCEPTED BY THE NATIONAL MEDICAL PRODUCTS ADMINISTRATION OF THE PRC](https://www1.hkexnews.hk/listedco/listconews/sehk/2026/0618/2026061801786.pdf) 17. 2026-05-29 HKEXnews [CHANGE OF AUTHORISED REPRESENTATIVE AND CHANGE OF BOOK CLOSURE PERIOD AND RECORD DATE](https://www1.hkexnews.hk/listedco/listconews/sehk/2026/0529/2026052903628.pdf) 18. 2026-05-28 HKEXnews [NOTICE OF ANNUAL GENERAL MEETING](https://www1.hkexnews.hk/listedco/listconews/sehk/2026/0528/2026052802205.pdf) 19. 2026-05-28 HKEXnews [PROPOSED RE-ELECTION AND APPOINTMENTS OF DIRECTORS OF THE SECOND SESSION OF THE BOARD](https://www1.hkexnews.hk/listedco/listconews/sehk/2026/0528/2026052802181.pdf) 20. 2026-05-28 HKEXnews [PROPOSED ABOLISHMENT OF THE BOARD OF SUPERVISORS, PROPOSED AMENDMENTS TO THE ARTICLES OF ASSOCIATION AND PROPOSED AMENDMENTS TO CERTAIN GOVERNANCE RULES](https://www1.hkexnews.hk/listedco/listconews/sehk/2026/0528/2026052802177.pdf) ## Stock chart Price chart and quote supplied by TradingView, delayed as the exchange requires. It loads only if you choose to show it. Information only, not investment advice. [Open HKEX:6887 on TradingView](https://www.tradingview.com/symbols/HKEX-6887/). ## Listing details Sunshine Lake Pharma Co., Ltd. is a public biotech or pharmaceutical company listed on HKEX under the ticker 6887, recorded under China. The directory classifies it as Biotechnology. aibio.space tracks 2,820 public biotech companies worldwide and publishes investor news on them. - **Company**: Sunshine Lake Pharma Co., Ltd. - **Ticker**: 6887 - **Listing**: HKEX - **Country or territory**: China - **Business scope**: Biotechnology - **ISIN**: CNE1000070M8 - **Last quote in directory**: 2026-10-22 - **Directory source**: [Listing page](https://www.tradingview.com/symbols/HKEX-6887/) Listing facts come from our company directory, researched on October 22, 2026. A listing record does not certify that a security currently trades. [Tell us about a change](https://aibio.space/reputation/#update). Work at this company? [Claim this page](https://aibio.space/claim/). Published and maintained by aibio.space. Not investment advice. [How we work](https://aibio.space/disclosures/). Who manages this page **This page is managed by aibio.space.** The company does not run, edit or pay for this page. News, desk views and Investor Ranks are written and managed independently by aibio.space under our editorial and analytical judgment. Opinion only, not investment advice. [How we work](https://aibio.space/disclosures/#paid) · [Terms](https://aibio.space/terms/#news) · [Request a correction](https://aibio.space/reputation/#update) --- Source page: https://aibio.space/companies/sunshine-lake-pharma/. Facts in aibio.space stories are checked against company filings and releases; opinion is labelled. Cite as: aibio.space, "Sunshine Lake Pharma Co. (6887) stock and investor profile", 2026-10-31, https://aibio.space/companies/sunshine-lake-pharma/